Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma

Area of Science:

• Cell Biology
• Oncology
• Biochemistry

Background:

• Autophagy is a fundamental catabolic process for cellular homeostasis, involving the degradation of damaged components via autophagosomes and lysosomes.
• Dysregulation of autophagy is implicated in various human diseases, presenting therapeutic targets.
• Cancer cells, including cholangiocarcinoma (CCA), exploit autophagy for survival, invasiveness, and resistance to chemotherapy.

Purpose of the Study:

• To review clinical and preclinical evidence on autophagy deregulation in cholangiocarcinogenesis.
• To evaluate the therapeutic potential of autophagy modulators in treating cholangiocarcinoma.

Main Methods:

• Collection and synthesis of clinical data on autophagy alterations in CCA development.
• Analysis of preclinical studies investigating compounds that modulate autophagy for CCA treatment.

Main Results:

• Autophagy appears impaired in early CCA stages but upregulated in established tumors and invasive phenotypes.
• Preclinical studies demonstrate that autophagy modulators can induce CCA cell death.
• Modulating autophagy shows potential in reducing CCA invasiveness and resensitizing cells to chemotherapy.

Conclusions:

• Autophagy plays a complex role in cholangiocarcinoma progression, with distinct roles in early and late stages.
• Targeting autophagy presents a promising therapeutic strategy for cholangiocarcinoma, potentially improving treatment efficacy and overcoming resistance.